Ontology of Cardiovascular Drug Adverse Events
270 terms(s) returned
| Term Type: | Record: 51 to 100 of 270 Records | Page: 2 of 6, First Previous Next Last | Show Records Per Page |
- Cerebral Arterial Vasodilation [PE]
- Cerebral Hemorrhage [Disease/Finding]
- Cerebral Infarction [Disease/Finding]
- Cerebrovascular Disorders [Disease/Finding]
- Chemical Classes for Pharmacologic Classification [Chemical/Ingredient]
- Chemical Ingredients [Chemical/Ingredient]
- Chest Pain [Disease/Finding]
- Child [Disease/Finding]
- Chinese translation
- Chlorobenzoates [Chemical/Ingredient]
- Chlorothiazide [Chemical/Ingredient]
- Cholestasis [Disease/Finding]
- Cholestasis, Extrahepatic [Disease/Finding]
- Cholestasis, Intrahepatic [Disease/Finding]
- Cholesterol Absorption Alteration [PE]
- Cholesterol Metabolism Alteration [PE]
- Cholesterol Synthesis Alteration [PE]
- Cholesterol Synthesis Inhibitors [MoA]
- Cholestyramine Resin [Chemical/Ingredient]
- Cimetidine [Chemical/Ingredient]
- Cinchona Alkaloids [Chemical/Ingredient]
- Cinnarizine [Chemical/Ingredient]
- Cisapride [Chemical/Ingredient]
- Class_Code
- Class_Description
- Clinical Kinetics [PK]
- Clonidine Hydrochloride [Chemical/Ingredient]
- Clonidine [Chemical/Ingredient]
- Clostridium Infections [Disease/Finding]
- Cluster Headache [Disease/Finding]
- Coagulation Activity Alteration [PE]
- Colic [Disease/Finding]
- Colitis [Disease/Finding]
- Colitis, Ulcerative [Disease/Finding]
- Colonic Diseases [Disease/Finding]
- Conduction System Depolarization [PE]
- Conduction System Repolarization [PE]
- Congenital Abnormalities [Disease/Finding]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [Disease/Finding]
- Conjunctival Arterial Vasoconstriction [PE]
- Connective Tissue Diseases [Disease/Finding]
- Consciousness Disorders [Disease/Finding]
- Coronary Arterial Vasodilation [PE]
- Coronary Artery Disease [Disease/Finding]
- Coronary Disease [Disease/Finding]
- Coronary Thrombosis [Disease/Finding]
- Craniocerebral Trauma [Disease/Finding]
- Cream [Dose Form]
- Cutaneous Arterial Vasoconstriction [PE]
- Cutaneous Arterial Vasodilation [PE]
